LOAME
MED icon

Lombard Odier Asset Management (Europe)’s Medifast MED Stock Holding History

Lombard Odier Asset Management (Europe)’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,279
Closed -$1.17M – 277
2023
Q1 		$1.17M Sell
11,279
-16,841
-60% -$1.87M 0.06% 220
2022
Q4 		$3.24M Buy
28,120
+10,700
+61% +$1.25M 0.13% 161
2022
Q3 		$1.89M Buy
+17,420
New +$2.5M 0.1% 179

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Lombard Odier Asset Management (Europe)'s MED Position: Q2 2023 in Review

Lombard Odier Asset Management (Europe) sold out of Medifast (MED) in Q2 2023, closing a stake of 11,279 shares — an estimated $1.17M sold.

Lombard Odier Asset Management (Europe) first reported a position in MED in Q3 2022 and held it in 3 quarters. The position peaked at $3.24M in Q4 2022. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

  • Lombard Odier Asset Management (Europe) reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
  • Lombard Odier Asset Management (Europe) sold 11,279 Medifast shares in Q2 2023, an estimated $1.17M.
  • Lombard Odier Asset Management (Europe) first reported a position in Medifast in Q3 2022 and held it in 3 quarters.
  • Lombard Odier Asset Management (Europe)'s Medifast position peaked at $3.24M in Q4 2022.
  • 236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Lombard Odier Asset Management (Europe)'s 13F filing for Q2 2023, filed 14 Aug 2023.